This was a case-case study among @ patients defined as high risk ( tumor size > @ cm and/or nodal involvement ; n = @ ) or low risk ( @ cm , node negative ; n = @ ) within the mitomycin-C arm of the Radiation Therapy Oncology Group @-@ trial .